Cabozantinib: An evolving therapy for hepatocellular carcinoma.

El-Khoueiry AB, Hanna DL, Llovet J, Kelley RK. Cabozantinib: An evolving therapy for hepatocellular carcinoma. Cancer Treat Rev. 2021 Jul; 98:102221.

View in: PubMed

subject areas

Anilides
Animals
Antineoplastic Agents
Carcinoma, Hepatocellular
Humans
Liver Neoplasms
Pyridines

authors with profiles

Robin Kelley

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement